Abbott Laboratories Stock NEO Exchange
Stocks
ABT
CA0028221046
Medical Equipment, Supplies & Distribution
| Market Cap | 187B 161B 151B 138B 260B 17,792B 264B 1,770B 695B 8,901B 700B 685B 29,645B | P/E 2026 * |
30.9x | P/E 2027 * | 23.8x |
|---|---|---|---|---|---|
| Enterprise Value | 211B 182B 171B 156B 294B 20,097B 298B 1,999B 785B 10,054B 791B 774B 33,485B | EV / Sales 2026 * |
4.19x | EV / Sales 2027 * | 3.81x |
| Free-Float |
86.16% | Yield 2026 * |
2.38% | Yield 2027 * | 2.52% |
Last Transcript: Abbott Laboratories
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 2023-08-31 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 2011-12-08 |
Daniel Starks
BRD | Director/Board Member | 71 | 2017-02-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 187B | |
| +0.82% | +1.07% | -17.58% | +3.37% | 187B | |
| +2.10% | +2.33% | -4.36% | +6.71% | 112B | |
| +1.04% | +4.76% | +11.13% | +72.72% | 61.15B | |
| +2.38% | +6.38% | +35.52% | +59.33% | 54.39B | |
| +0.96% | +4.47% | -7.63% | -35.86% | 48.17B | |
| +3.62% | +0.02% | +12.18% | -22.90% | 31.98B | |
| -3.96% | -16.58% | - | - | 30.91B | |
| +0.22% | +2.13% | +47.85% | -11.22% | 24.92B | |
| +0.09% | +1.51% | -2.26% | +3.93% | 23.15B | |
| Average | +0.55% | +1.86% | +9.36% | +9.51% | 63.64B | |
| Weighted average by Cap. | +0.71% | +2.17% | +0.02% | +11.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.3B 43.55B 40.7B 37.2B 70.1B 4,798B 71.2B 477B 187B 2,400B 189B 185B 7,994B | 54.65B 47.31B 44.22B 40.41B 76.16B 5,212B 77.35B 519B 203B 2,607B 205B 201B 8,684B |
| Net income | 6.23B 5.39B 5.04B 4.61B 8.68B 594B 8.82B 59.12B 23.2B 297B 23.4B 22.88B 990B | 7.93B 6.87B 6.42B 5.87B 11.06B 757B 11.23B 75.29B 29.54B 379B 29.79B 29.14B 1,261B |
| Net Debt | 24.17B 20.92B 19.55B 17.87B 33.68B 2,305B 34.2B 229B 89.98B 1,153B 90.74B 88.76B 3,840B | 21.42B 18.54B 17.33B 15.84B 29.85B 2,043B 30.31B 203B 79.74B 1,022B 80.42B 78.66B 3,403B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
